Ursa Major Technologies Is Going Public via SPAC — Here's the Setup
Ursa Major Technologies, an aerospace and defense company focused on hypersonics, solid rocket motors, and space mobility systems, is going public via a merger with Bleichroeder Acquisition Corp. III (BCCQ). The deal is expected to close in Q1 2027 and list on Nasdaq under IPXX. The setup offers exposure to defense demand, but shareholders should watch redemption risk, PIPE dilution, and whether the company can convert projections into contracted revenue.
Ursa Major Technologies, an aerospace and defense company focused on hypersonics, solid rocket motors, and space mobility systems, is going public via a merger with Bleichroeder Acquisition Corp. III (BCCQ). The deal is expected to close in Q1 2027 and list on Nasdaq under IPXX. The setup offers exposure to defense demand, but shareholders should watch redemption risk, PIPE dilution, and whether the company can convert projections into contracted revenue.
Deal at a Glance
SPAC partner: Bleichroeder Acquisition Corp. III
SPAC ticker (trades now): BCCQ
Expected post-merger ticker: IPXX
Implied valuation: $2.3B post-transaction equity
Expected close: Q1 2027
Est. first trading date: Q1 2027
Deal status:
Announced
Source filing: SEC 425 (2026-08-25)
Company Overview
Ursa Major Technologies is an aerospace and defense company built around hypersonics, solid rocket motors, liquid propulsion, and in-space mobility systems. Its product set includes the HAVOC Missile System, powered by the Draper engine and boosted by in-house solid rocket motors, plus the Hadley and Draper liquid engines and tactical/operational solid rocket motors for boosters and missile applications. The company says it was founded in 2015, is headquartered in Berthoud, Colorado, and has additive manufacturing operations in Youngstown, Ohio.
The company’s deck says it has 360+ employees and 6 facilities across nearly 500 acres, with 500+ ground tests and 5,500+ seconds of test time. Management is pitching Ursa Major as a scaled defense-industrial-base supplier at a time when the U.S. is trying to expand hypersonic and SRM capacity. The deck cites $17B+ of FY2026 addressable spend for long-range, survivable all-up rounds and $12B+ of SRM value tied to critical munitions, though those are management estimates. The competitive field is crowded at the top end, with large primes and a small set of emerging suppliers.
The SPAC Deal
Ursa Major is merging with Bleichroeder Acquisition Corp. III, which currently trades as BCCQ. The deal announcement values Ursa Major at about $1.6 billion pre-money equity and about $2.3 billion post-transaction equity. The sources-and-uses table shows $1.6 billion of equity to Ursa Major, $345 million from the SPAC trust, and $350 million of PIPE financing, for $2.295 billion of sources, with $670 million of cash expected to the balance sheet and $25 million of estimated transaction expenses.
The trust account is meaningful but not guaranteed. Bleichroeder’s IPO filing and 10-Q show $345.0 million in trust from 34.5 million units sold at $10.00 each, plus a portion of private placement warrant proceeds. The deal deck says Ursa Major may retain up to $345 million in additional proceeds depending on redemptions, and the sources-and-uses assumes 0% redemptions. That is the key SPAC variable: if public holders redeem heavily, cash to the company falls even if the headline valuation stays the same. The merger agreement also provides redemption rights for public shareholders.
Financing is anchored by at least $350 million of PIPE commitments, with about $110 million funded at signing, led by Inflection Point and including new institutional investors and existing Ursa Major investors, including XN. Dilution is still real: Bleichroeder sold 34.5 million public units, 8.5 million private placement warrants were sold at $1.00 each, and the merger structure includes sponsor lock-up and seller lock-up agreements plus Series A Preferred Stock and Series A Investor Warrants. The deal was announced August 25, 2026, and closing is anticipated in Q1 2027. The company said it will file an S-4/proxy prospectus, but no definitive proxy, vote date, or closing completion has been disclosed yet. The combined company is expected to trade on Nasdaq under IPXX, while the SPAC trades today under BCCQ.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
The SPAC route gives Ursa Major a faster path to public capital than a traditional IPO and lets the company package a large financing stack around a defense story that is still in scale-up mode. The transaction also brings in sponsor backing and PIPE support alongside the trust cash, which matters for a capital-intensive business that wants to expand manufacturing capacity and production throughput.
It also allows management to present forward projections more directly than a standard IPO process typically would. Ursa Major’s deck includes 2026E revenue of $101 million and a 2027E revenue opportunity of about $200 million, which helps frame the growth story for public investors. That said, the market will judge whether those projections are backed by contracts, production execution, and customer demand rather than just addressable-market slides.
Financial Highlights
Ursa Major’s deck shows revenue rising from $18.5 million in 2024A to $45 million in 2025A, with 2026E revenue of $101 million and a 2027E revenue opportunity of about $200 million. Those 2026 and 2027 figures are projections, not historical results, but they show why the company is being marketed as a scale story rather than a mature defense contractor.
The deck also shows gross margin at 50% / 44% / 27% across FY25 / FY26E / FY27E, indicating that margin mix may fluctuate as the business scales and product mix changes. The filing set provided here does not disclose a full cash-flow or net income bridge, so shareholders should focus on the combination of revenue ramp, margin trajectory, and how much cash actually lands on the balance sheet after redemptions and deal expenses. The headline is that the deal is designed to fund growth, but the actual runway depends on closing proceeds and execution after the merger.
Risk Factors
The biggest de-SPAC risk is redemption pressure. The SPAC trust holds $345 million, but the deal deck assumes 0% redemptions, and the company says it may retain up to $345 million in additional proceeds depending on redemptions. If public holders pull cash, the balance sheet shrinks even though the valuation headline does not. That can force the company to rely more heavily on PIPE capital or future financing.
Dilution is another major overhang. The structure includes public units, private placement warrants, sponsor economics, and PIPE preferred stock and warrants. That means the equity base can expand quickly after closing, which can mute per-share upside if the business does not outgrow the capital structure. There is also deal risk: the transaction is announced and pending, not yet closed, and the S-4/proxy still has to move through the SEC and shareholder process.
Operationally, shareholders should watch whether Ursa Major can convert its test record and projected revenue into repeatable production and customer orders. The company is operating in a defense market dominated by large incumbents such as Northrop Grumman and L3Harris/Aerojet Rocketdyne, so execution risk is real. Cash runway is also a question: the deal is meant to deliver $670 million to the balance sheet before expenses, but that figure is sensitive to redemptions and closing costs.
Comparable Public Companies
Public comps used by bankers and investors around this deal include Kratos (KTOS), AeroVironment (AVAV), Leonardo DRS (DRS), Mercury Systems (MRCY), and Curtiss-Wright (CW). These names span defense electronics, unmanned systems, and mission-critical components, so they are not perfect matches for Ursa Major’s propulsion-heavy model, but they help frame how the market pays for defense growth and technical differentiation.
The broader comp set has generally been treated as a quality-growth defense basket rather than a deep-value group, with investors rewarding companies that can show backlog, program visibility, and margin durability. Ursa Major is earlier-stage than most of these peers, so the market will likely compare it less on current earnings and more on revenue ramp, manufacturing scale, and whether the hypersonics and SRM opportunity can become a durable contracted business. The key point: the company is being priced like a growth defense platform, not a legacy prime.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
This is a classic de-SPAC setup where the headline valuation is only part of the story. The real question is how much of the $345 million trust survives redemptions, how much dilution the PIPE and warrant structure creates, and whether Ursa Major can turn its test milestones into sustained revenue growth after the merger closes.
Shareholders should watch the S-4/proxy, the redemption window, and any updates on financing before the expected Q1 2027 close. Why this matters now: the deal gives public-market investors a rare way to play hypersonics and solid rocket motor capacity, but the stock’s first months after listing on Nasdaq as IPXX will likely be driven as much by capital structure mechanics as by the underlying defense story.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.